Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
6.05
-0.35 (-5.47%)
Aug 14, 2025, 2:19 PM - Market open
Candel Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 100.69 | 102.65 | 35.41 | 70.06 | 82.64 | 35.05 | Upgrade
|
| Cash & Short-Term Investments | 100.69 | 102.65 | 35.41 | 70.06 | 82.64 | 35.05 | Upgrade
|
| Cash Growth | 369.32% | 189.88% | -49.45% | -15.23% | 135.76% | -22.20% | Upgrade
|
| Prepaid Expenses | 2.92 | 1.15 | 1.38 | 1.89 | 2.3 | 0.09 | Upgrade
|
| Total Current Assets | 103.61 | 103.8 | 36.8 | 71.95 | 84.95 | 35.15 | Upgrade
|
| Property, Plant & Equipment | 2.05 | 2.73 | 4.02 | 5.48 | 3.84 | 2.79 | Upgrade
|
| Other Long-Term Assets | 0.31 | 0.33 | 0.38 | 0.27 | 0.42 | 0.35 | Upgrade
|
| Total Assets | 105.97 | 106.87 | 41.2 | 77.69 | 89.21 | 38.28 | Upgrade
|
| Accounts Payable | 1.95 | 0.24 | 0.42 | 0.38 | 1.59 | 0.92 | Upgrade
|
| Accrued Expenses | 4.32 | 4.72 | 3.96 | 4.72 | 3.44 | 3.14 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 0.46 | Upgrade
|
| Current Portion of Long-Term Debt | 6.7 | 9.9 | 8.89 | - | - | - | Upgrade
|
| Current Portion of Leases | 0.59 | 0.57 | 0.51 | 0.46 | - | - | Upgrade
|
| Other Current Liabilities | 1.15 | 22.11 | 0.4 | 0.05 | 0.33 | 0.19 | Upgrade
|
| Total Current Liabilities | 14.72 | 37.53 | 14.18 | 5.62 | 5.36 | 4.71 | Upgrade
|
| Long-Term Debt | 0.94 | 2.6 | 12.38 | 20.85 | 0.56 | 0.48 | Upgrade
|
| Long-Term Leases | 0.1 | 0.41 | 0.97 | 1.49 | - | - | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | 0.14 | - | 0.13 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.92 | 1.88 | 19.15 | 7.46 | Upgrade
|
| Total Liabilities | 15.76 | 40.54 | 28.46 | 29.98 | 25.07 | 12.78 | Upgrade
|
| Common Stock | 0.55 | 0.47 | 0.29 | 0.29 | 0.29 | 0.12 | Upgrade
|
| Additional Paid-In Capital | 279.73 | 258.51 | 149.93 | 146.96 | 144.15 | 20.49 | Upgrade
|
| Retained Earnings | -189.62 | -192.21 | -137.03 | -99.09 | -80.3 | -44.17 | Upgrade
|
| Treasury Stock | -0.45 | -0.45 | -0.45 | -0.45 | - | - | Upgrade
|
| Total Common Equity | 90.21 | 66.33 | 12.75 | 47.71 | 64.14 | -23.56 | Upgrade
|
| Shareholders' Equity | 90.21 | 66.33 | 12.75 | 47.71 | 64.14 | 25.5 | Upgrade
|
| Total Liabilities & Equity | 105.97 | 106.87 | 41.2 | 77.69 | 89.21 | 38.28 | Upgrade
|
| Total Debt | 8.34 | 13.47 | 22.76 | 22.8 | 0.56 | 0.95 | Upgrade
|
| Net Cash (Debt) | 92.35 | 89.18 | 12.65 | 47.26 | 82.08 | 34.11 | Upgrade
|
| Net Cash Growth | 3092.05% | 604.95% | -73.23% | -42.43% | 140.66% | -23.59% | Upgrade
|
| Net Cash Per Share | 2.18 | 2.82 | 0.44 | 1.64 | 4.35 | 2.94 | Upgrade
|
| Filing Date Shares Outstanding | 54.9 | 47.24 | 29.35 | 28.92 | 28.69 | 11.64 | Upgrade
|
| Total Common Shares Outstanding | 54.89 | 46.81 | 29.09 | 28.92 | 28.69 | 11.64 | Upgrade
|
| Working Capital | 88.89 | 66.28 | 22.61 | 66.33 | 79.58 | 30.43 | Upgrade
|
| Book Value Per Share | 1.64 | 1.42 | 0.44 | 1.65 | 2.24 | -2.03 | Upgrade
|
| Tangible Book Value | 90.21 | 66.33 | 12.75 | 47.71 | 64.14 | -23.56 | Upgrade
|
| Tangible Book Value Per Share | 1.64 | 1.42 | 0.44 | 1.65 | 2.24 | -2.03 | Upgrade
|
| Machinery | - | 2.16 | 2.19 | 2.5 | 1.19 | 1.4 | Upgrade
|
| Construction In Progress | - | - | - | - | - | 1.22 | Upgrade
|
| Leasehold Improvements | - | 3.11 | 3.11 | 3.06 | 2.99 | 0.31 | Upgrade
|
Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.